The latest closing stock price for Supernus Pharmaceuticals as of September 20, 2024 is 31.82.
An investor who bought $1,000 worth of Supernus Pharmaceuticals stock at the IPO in 2012 would have $4,926 today, roughly 5 times their original investment - a 15.98% compound annual growth rate over 12 years.
The all-time high Supernus Pharmaceuticals stock closing price was 59.85 on June 29, 2018.
The Supernus Pharmaceuticals 52-week high stock price is 35.44, which is 11.4% above the current share price.
The Supernus Pharmaceuticals 52-week low stock price is 21.99, which is 30.9% below the current share price.
The average Supernus Pharmaceuticals stock price for the last 52 weeks is 29.07.
An investor who bought $1,000 worth of Supernus Pharmaceuticals stock at the IPO in 2012 would have $4,926 today, roughly 5 times their original investment - a 15.98% compound annual growth rate over 12 years.
The all-time high Supernus Pharmaceuticals stock closing price was 59.85 on June 29, 2018.
The Supernus Pharmaceuticals 52-week high stock price is 35.44, which is 11.4% above the current share price.
The Supernus Pharmaceuticals 52-week low stock price is 21.99, which is 30.9% below the current share price.
The average Supernus Pharmaceuticals stock price for the last 52 weeks is 29.07.